Here are five things to know.
1. Some recalled devices may contain a blocked guidewire lumen. The defect would prevent clinicians from properly positioning the device and delay life-saving treatment to control hemorrhaging.
2. The recall applies to catheters distributed between Feb. 24 and July 31.
3. Spectranetics first warned clinicians of the potential product flaw Aug. 7, urging clinicians to assess the device and ensure the guidewire lumen is unblocked prior to using the catheter.
4. The company sent out a second notice Aug. 21, saying the product flaw could occur in any Bridge Occlusion Balloon Catheter.
5. Spectranetics will arrange for the return and replacement of affected catheters once the product issue is permanently resolved.
More articles on supply chain:
FDA takes action against 500 websites illegally selling prescription medicine
Medline director of sales Brian Garner on the impact of mobility on a patient’s confidence
FDA: Major drug shortages possible after Hurricane Maria
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
